Molecular and Cellular Biology, September 2001, p. 5699-5709, Vol. 21, No. 17
Department of Genetics and Microbiology,
University of Geneva Medical School, CMU, 1211 Geneva, Switzerland
Received 16 January 2001/Returned for modification 19 February
2001/Accepted 11 June 2001
Major histocompatibility complex class II (MHCII) molecules
play a pivotal role in the immune system because they direct the development and activation of CD4+ T cells. There are three
human MHCII isotypes, HLA-DR, HLA-DQ, and HLA-DP. Key transcription
factors controlling MHCII genes have been identified by virtue of the
fact that they are mutated in a hereditary immunodeficiency resulting
from a lack of MHCII expression. RFXAP
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.17.5699-5709.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Expression of the Three Human Major Histocompatibility Complex
Class II Isotypes Exhibits a Differential Dependence on the
Transcription Factor RFXAP
one of the factors affected in
this disease
is a subunit of RFX, a DNA-binding complex that
recognizes the X box present in all MHCII promoters. To facilitate
identification of conserved regions in RFXAP, we isolated the mouse
gene. We then delimited conserved domains required to restore
endogenous MHCII expression in cell lines lacking a functional
RFXAP gene. Surprisingly, we found that 80% of RFXAP is
dispensable for the reactivation of DR expression. Only a short
C-terminal segment of the protein is essential for this isotype. In
contrast, optimal expression of DQ and DP requires a larger C-terminal
segment. These results define an RFXAP domain with an MHCII
isotype-specific function. Expression of the three MHCII isotypes
exhibits a differential requirement for this domain. We show that this
is due to a differential dependence on this domain for promoter
occupation and recruitment of the coactivator CIITA in vivo.
*
Corresponding author. Mailing address: Department of
Genetics and Microbiology, University of Geneva Medical School, CMU, 1 rue Michel-Servet, 1211 Geneva, Switzerland. Phone: 41 22 702 56 66. Fax: 41 22 702 57 02. E-mail:
walter.reith{at}medecine.unige.ch.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|